Alpha thalassemia and stroke risk in sickle cell anemia.
In an effort to identify possible risk factors for stroke in Sickle Cell Anemia (Hb SS), we analyzed the distribution of alpha-globin gene deletions in a group of Hb SS patients with and without stroke. The group with stroke consisted of 44 patients, (27 male, 17 female) with a mean of 7.5 years at time of stroke. The control group (non-stroke) had 256 Hb SS patients (126 male, 130 female) with a mean age of 7.7 years. There were 9 patients with heterozygous alpha-thalassemia in the stroke group (20.5%). In the control group, there were 93 patients with heterozygous alpha-thalassemia and 5 with homozygous alpha-thalassemia. The incidence of alpha-thalassemia in Hb SS patients without stroke (38%) was comparable to that reported for the African-American population in general. The incidence in the stroke population (20.5%) was significantly lower (P = 0.02) These results indicate that alpha-thalassemia is associated with a lower risk of stroke in Hb SS. This observation should be confirmed in studies involving larger numbers of patients. Possible protective effects of alpha-thalassemia are unknown but may be related to decreased hemolysis and more favorable rheologic properties of red blood cells.
Adams
R J
RJ
Department of Neurology, Medical College of Georgia, Augusta 30912.
Kutlar
A
A
McKie
V
V
Carl
E
E
Nichols
F T
FT
Liu
J C
JC
McKie
K
K
Clary
A
A
D000293:Adolescent; D000328:Adult; D000755:Anemia, Sickle Cell / Q000150:complications* / Q000235:genetics; D044383:Black People / Q000235:genetics; D002561:Cerebrovascular Disorders / Q000453:epidemiology* / Q000209:etiology / Q000235:genetics; D002648:Child; D002675:Child, Preschool; D005260:Female; D017353:Gene Deletion; D006579:Heterozygote; D006720:Homozygote; D006801:Humans; D007223:Infant; D008297:Male; D015995:Prevalence; D012307:Risk Factors; D017085:alpha-Thalassemia / Q000453:epidemiology* / Q000209:etiology / Q000235:genetics; D001741:Black or African American